MAM
ALBO

Martingale Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Martingale Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,407
Closed -$386K – 919
2022
Q2 		$386K Buy
19,407
+100
+0.5% +$2.64K 0.01% 698
2022
Q1 		$577K Hold
19,307
– – 0.01% 609
2021
Q4 		$451K Buy
19,307
+100
+0.5% +$2.66K 0.01% 667
2021
Q3 		$600K Buy
19,207
+11,600
+152% +$359K 0.01% 626
2021
Q2 		$269K Buy
7,607
+100
+1% +$3.25K ﹤0.01% 739
2021
Q1 		$266K Buy
7,507
+1,007
+15% +$37.2K ﹤0.01% 769
2020
Q4 		$245K Sell
6,500
-8,200
-56% -$298K ﹤0.01% 792
2020
Q3 		$492K Buy
+14,700
New +$428K 0.01% 818

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Martingale Asset Management's ALBO Position: Q3 2022 in Review

Martingale Asset Management sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 19,407 shares — an estimated $386K sold.

Martingale Asset Management first reported a position in ALBO in Q3 2020 and held it in 8 quarters. The position peaked at $600K in Q3 2021. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Martingale Asset Management reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • Martingale Asset Management sold 19,407 Albireo Pharma Inc shares in Q3 2022, an estimated $386K.
  • Martingale Asset Management first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 8 quarters.
  • Martingale Asset Management's Albireo Pharma Inc position peaked at $600K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Martingale Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.